Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

100 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Combination With Low-dose Dextromethorphan Improves the Effect of Amlodipine Monotherapy in Clinical Hypertension: A First-in-human, Concept-proven, Prospective, Dose-escalation, Multicenter Study.
Yin WH, Chen P, Yeh HI, Wang KY, Hung YJ, Tseng WK, Wen MS, Wu TC, Wu CC, Cheng SM, Chen JW. Yin WH, et al. Among authors: tseng wk. Medicine (Baltimore). 2016 Mar;95(12):e3234. doi: 10.1097/MD.0000000000003234. Medicine (Baltimore). 2016. PMID: 27015224 Free PMC article. Clinical Trial.
Observational study of dronedarone in Taiwanese patients with atrial fibrillation.
Lin JL, Wu TJ, Chen CP, Hsu JC, Ueng KC, Kuo JY, Chen MC, Yeh KH, Chang KC, Lu YY, Shyu KG, Wen MS, Chen SA, Hsieh MH, Tseng WK, Feng AN, Yang TY, Ko WC, Cheng CW, Liu JC, Lai WT. Lin JL, et al. Among authors: tseng wk. J Formos Med Assoc. 2020 Jan;119(1 Pt 1):59-68. doi: 10.1016/j.jfma.2019.03.009. Epub 2019 Apr 22. J Formos Med Assoc. 2020. PMID: 31023506 Free article.
Guideline-adherent therapy in patients with cardiovascular diseases in Taiwan.
Jeng JS, Yin WH, Huang CC, Chuang SY, Yeh HI, Fang CC, Lin TH, Wang KY, Tseng WK, Huang LC, Ueng KC, Hsieh IC, Li YH, Pan WH, Wu CC, Chen JW; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators. Jeng JS, et al. Among authors: tseng wk. J Formos Med Assoc. 2015 Oct;114(10):1000-7. doi: 10.1016/j.jfma.2013.10.007. Epub 2013 Nov 22. J Formos Med Assoc. 2015. PMID: 24275017 Free article.
Determinants for achieving the LDL-C target of lipid control for secondary prevention of cardiovascular events in Taiwan.
Ho LT, Yin WH, Chuang SY, Tseng WK, Wu YW, Hsieh IC, Lin TH, Li YH, Huang LC, Wang KY, Ueng KC, Fang CC, Pan WH, Yeh HI, Wu CC, Chen JW; Taiwanese Secondary Prevention for patients with AtheRosCLErotic disease (T-SPARCLE) Registry Investigators. Ho LT, et al. Among authors: tseng wk. PLoS One. 2015 Mar 10;10(3):e0116513. doi: 10.1371/journal.pone.0116513. eCollection 2015. PLoS One. 2015. PMID: 25756522 Free PMC article.
Lipid lowering therapy in patients with atherosclerotic cardiovascular diseases: Which matters in the real world? Statin intensity or low-density lipoprotein cholesterol level? ‒ Data from a multicenter registry cohort study in Taiwan.
Yeh YT, Yin WH, Tseng WK, Lin FJ, Yeh HI, Chen JW, Wu YW, Wu CC; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators. Yeh YT, et al. Among authors: tseng wk. PLoS One. 2017 Oct 26;12(10):e0186861. doi: 10.1371/journal.pone.0186861. eCollection 2017. PLoS One. 2017. PMID: 29073192 Free PMC article.
100 results